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INTRODUCTION 
u u u 
(1) 
Malaria has the highest incidence among the various parasitic diseases and 
remains a leading cause of mortality and morbidity in many part of the world, 
especially the tropical and subtropical region of the world. According to a careful 
estimation it has 300 to 500 million clinical case every yeat and 1.5 to 2.7 million 
deaths per year. The 90% death due to malaria occurs in Africa. (TDR News 
1991 and 1994) The disease wtiich was on the verge of eradication as a result of 
concerted efforts of World Health Orzanization (WHO) virtth National Goverment in 
the early sixties has shown resurgence due to appearance of parasite strains and 
insect vactors resistant to various eradication measure. This created a renewed 
interst in basic malaria research oriented towards better understanding of 
Immunology, Biochemistry and Biology of malaria parasite in order to develop 
effective control strategies. 
In India, malaria has been one of the most mischeivious menace. The 
incidence of disease which as a result of National Malaria Eradication Programme 
was brought to under one million cases per year, has been increasing significantly 
and at present approximatily 1.5 to 2.6 million cases are recorded ^very year. 
Malaria is caused by the protozoan parasite of genus Plasmodium the 
parasite undergoes a complex life cycle alternating between vertebrate and 
arthropod hosts. The life cycle of malaria parasite starts with the introduction of 
sporozoites during the bite of anopheline mosquito. The sporozoites travel quickly 
from the site of bite to the liver via blood stream in which they circulate for a short 
time and invade the parenchymatous cells and undergo exoerythrcytic (EE) 
schizogony. Within a few hrs of invasion in hepatocytes, the parasites start 
development and form tissue schizonts which harbour large number of EE 
merozoites The schizonts rupture and merozoites escape to liver sinosoids. 
The erythrocytic schizogony starts with the invasion of erythrocytes by 
merozoites and is completed in 24 to 48 hrs depending upon the species of 
malaria parasites. On maturation schionts rypture releasing merozoites which 
infect the fresh erythrocytes. After few cycle of erythrocytic schizogony some of 
(2) 
the merozoites invading the erythrocytes differentiate into sexual forms, the 
macrogametocytes and microgametocytes which are Ingested by female 
anophelese during Its blood meal from an infected host. In the midgut of the 
mosquito one macrogametocyte transforms into one macrogmete whereas, 
microgametocyte undergoes a process of exflagellation giving rise to eight 
microgametes. The macrogamete is fertilized by a microgamete resulting In 
formation of a zygote. The zygote matures into an ookinete which penetrates the 
mid gut and finally comes to rest on external surface where it rounds up into the 
oocyst 24 to 72 hrs after ingestion of blood, nuclear multiplication takes place and 
upto 10,000 spozoites are formed in a single oocyst. After the attainment of 
maturity the sporozoites escape from oocysts and travel into the heamocoelomic 
fluid and accumulate in the acenal cells of the salivary glands. These sporozoites 
are introduced into the blood stream of the vertebrate host when the female 
anopheline mosquito bites for its blood meal. 
The four species of genus Plasmodium which cause malaria infections In 
humans are Plasmodium falciparum commonly called malignant tertian malaria 
P vivax , benigs tertian malaria P. malariae, quartan malaria and P. ovale. Of 
these P. falciparum is the most dangerous and is responsible for approximately 
85% of the total cases of malaria worid wide. Infection with P. falciparum may 
lead to intravasular haemolysis and plugging of cerebral arteries resulting in 
cerebral malaria. As far as global scenario of malaria Incidence is concerned 
P. falciparum is followed by P. vivax while remaining two speoes have very limited 
and patchy foci. 40% of malaria incidence in India is reported In tribal population 
constitutes only 7.5% of the total population. Out of this 40% malaria cases 60% 
are P. falciparum (ICMR 1994). Malaria prevalence and menace has failed to 
improve because of emergence of parasite strains resistant to conventional 
antimalarials and their continued expansion to new geographical areas. Today, In 
some areas of the worid multiple drug resistance is so common that there is little 
to choose for the prophylaxis or terarment of malaria (Schapira et a! 1993). In 
India also drug resistant strains of Plasmodia have been found in various parts of 
(3) 
the country. The WHO has emphasized research on Chemotherapy of malaria 
including assessment and monitoring of drug sensitivity of malaria parasite the 
improvement in malaria treatment and development of effective and safe 
antimalarial compounds. 
After realizing the impending danger posed by the tiny and tricky parasites, 
researchers through out the worid started investigating the measure and means to 
overcome the threat in malaria treatment. The advent of cytokines, especially the 
interferons, at the arena of virology and its role as the immumomodulatory or 
immunoregulatory factors gave a sigh of relief to the workers in this endeveaur 
Interferons are the immunoregulatory and inflammatory cytokine. The term was 
coined by Isaacs and Lendenmann (1957). It referred to the substances that 
protected the cells against viral infections. Even after about 40 years of its 
discovery the complexiety of interferon is still being unravelled. Earlier the 
interferons were recognised on the basis of their physicochemical nature and 
classified on th basis of their origin viz. Leukocyte interferon fibroblast interferon 
and immune interferons. Depending upon the types of stimulus applied to induce 
interferon (I FN) synthesis also these are named like viral I FN or antigenic I FN. I FN 
were classified as type I and type II by (youngner and SaMn 1973) Type I 
includes virally induced fibroblast or leukocyte interferon whose activity was 
resistant to acid (pH-2) Type II interferon also referred as immune I FN by Falcoff 
(1972) was stable at 66^ C but remained acid labile and Is produced by mitogenic 
or antigenic stimutation. In 1978 Intarnatunal Nomenclature Committee introduced 
an alternative system of I FN designation based on letters of Greek alphabets. 
Leucocyte I FN became IFN-a Fibroblast interferen became IFN-p and type II 
(immune) interferon became IFN-y. (Meager A. 1990). IFN-oc, both in human and 
murine system had a set of molecular species designated by the numerals FN-a1 
and IFN-a2 with molecular weight ranging from 16,000 to 27,000 In human and 
around 20,000 in murine system. There is about 40% homology Is murine and 
human IFN-a subspecies. IFN-p is the fibroblast interferon human Interferon-p Is 
not much hetrogeneous and often referred to as IFN-pl The second type of IFN-p 
(4) 
was mistaken, which, later proved to be the B cell stimulating factor (BSF-2) and 
subsesquently named as IL-6, In murine IFN-p has p i , p2 and p3 sub types with 
appearent molecular weight approximately 3,500 (class A) and 26,000 (class B) 
both are glycopotein (Pestka et al 1987) It is about 60% homologous to human 
IFN-p. 
Lymphocyte in response to plant lectin, PHA or Con. A produces an IFN 
species called IFH-y It was demonstrated in 1960 (Meager 1990) sources of IFN 
include Thi PBMC (peripheral blood monocytes) and splenocytes. Generally IFN-y 
exists in dimer or trimer of one molecule (Mol wt. 20,000-25,000) Its functional 
unit is reported to be a tetramer (Yip et al 1982, Braud 1984 and Braud 1986). 
Expression of IFN-y is performed in £. co//very efficiently but the products are non 
glycosylated. The glycosylated form of IFN can be obtained by expressing the IFN 
genes in animals cells or yeast cells. Rather unfortunately most of the IFN-y in 
clinical trial are nonglycosylated, that is, of bacterial origin. By a lot of factors 
normal cells can be stimulated to produce interferons several cell types respond to 
diffrent stimuli by producing a mixture of interferons. Human diploid fibroblast cells 
produce mainly interferon-p but also produce a minor ammount of human IFN-ot, 
Cells of immune system produce IFN-a/IFN-p or IFN-y depending upon the 
stimulation applied. Normally, IFN genes are not expressed however, inducibllity 
apears to reside in IFN gene. There are many IFN inducer, eg viruses double 
stranded RNA (ds RNA) growth factors (Cytokines), ploy IC:LC ; NDV, statolon 
and 6-MFA. Poly IC:LC is a lysine conjugated synthetic double stranded RNA It is 
effective IFN inducer in rabbit and rodents (Field et al 1967). Statolon is a fungal 
product from Penicilium stoloniferum (Banks et ai 1968). It is effective in protecting 
animals fi-om mouse mammaty virus (MMV). 6-MFA is another fungal product that 
is considered to be IFN inducer It is a mould fillerate from Aspergillus species it is 
an Aceton Fraction. Eariier it has been reported that the product protects mice 
from semliki Forest Virus (SFV) (Chandra Maheshwari and Gupta 1971). It has 
further been contemplated that it is fungal RNA that induces the IFN. 
The effcieney of endogenous IFN produced during malaria infection has 
(5) 
been investigated against P. chabaudi AS and found that peak IFN-y production 
occurs just before and at the peak parasitemia. The monoclonal antibody against 
this pluripotent lymphokine was treated in blood stage infection and was found that 
IFN-y mAB impairs but not completely abrogates the host resistance to 
P. chabaudi (Stevenson MM et al 1990) Inhibitory effect of IFN is reported in 
exoerythrocytic stage of P. falaciparum in infected individuals. (Deloron P et al 
1991). Human IFN diminished parasitemia in chimpanazee with P. wVax infection 
(Ferreira A et al 1986). New castle Disease Virus (NDV) and Poly ribolnoslnic 
Polyribocytidylic acid (rl.rC) were Investigated in case of sporozoite Induced 
P. berghei infection. The results extended the spectrum of interferon inducer in 
protozoan P. berghei. They demounstrated a protective effect of IFN Inducers In 
murine malaria and suggested the protection is mediated by IFN. Virus induced 
serum when injected with P. berghei infection it gave significant protective effect in 
sporozoite infection however it had no effect after the parasite entered the 
erythrocytic phase ie. treatment after 45 hrs in rodent malarial sporozoite 
inoculation (Jahiel R.I.1970). 6-MFA from Aspergillus ochraceus has been 
reported to enhance the MST significantly when treated in three multiple doses 
keeping the above facts in view following objcitives were envisaged under the plan 
of the work. 
1. Production of 6-MFA from Aspergillus ochraceus fungus. 
2. Evaluation of Anti Semliki Forest Virus (SFV) activity of 6-MFA. 




Cytokine is a term coined by Cohen (1974). It is virtually impossible to 
defined cytokines precisely, tiowever, grossly it can be defined as a class of 
inducible, water soluble heterogeneous and proteinaceous mediator of animal 
origin. The molecular weight of this glycoprotein varies between 5000 to 50,000 
datton. It excercises speicfic receptor mediated effect on target cells or the 
mediator producing cells themselves. The mode of action of cytokine can be either 
autocrine (when the producing cells are themselves targetted) or paracrine (if the 
target cells are in viscinity or distant location of the producing cells). The cytokine 
mediate the process of (a) Mttogenesis required for cell proliferation, tissue 
development and repair, (b) Cel| function required for maintenance of 
homeostatic, defensSe mechanism and intergrated control of different physiological 
system (Meager 1990). in the simplest term the cytokine can be said "the 
language in which cells talk to each other" the sphere of cytokine is so big that it 
can embrace lymphoklne (term coined by Dumonde 1969), Monokine to various 
growth regulatory factors like the Interieukins Interferons and tumor necrosis 
factors (Aral K. et an 990) 
Interferons are the immunoregulatory and inflammatory cytokine and the 
term coined by Isaacs and Lindenmann (1957) referred to substances that 
protected the cells against viral infection. Even 38 year or more of its discovery the 
complexity of interferon is being still unravelled. Eariier the interferons were 
recognized on the basis of their physico-chemical nature and classicfied on the 
basis of their origin viz. Leukocyte I FN, Fibroblast interferon and Immune 
interferon. Also depending upon the type of stimulus applied to induce I FN 
synthesis eg viral or antigenic and the acid lability of interferons so Induced (Pestka 
& Baron 1981), Interferons were also classified as type I and type II (youngner 
and SaMn 1973). Type I includes virally induced fiblofibroblast or leukocyte 
interferons whose activity was resistant to acid (pH-2). Type II interferon also 
referred as immune interferon by Falcoff (1972) was stable at 56 0 C but remained 
acid labile interferon produced by Lymphocyte following mitogenic or antigenic 
(7) 
stimulation. In 1978 an International Nomenclature Committee introduced an 
alternative system of I FN designation based on the letters of Greek alphabets. 
Leukocyte interferon became Interferon-a, fibroblast interferon became IFN-p and 
type II (immune) becamelFN-y (Meager A 1990). 
IFN g 
The detailed study of IFN was carried out only after about 20 years of its 
first isolation, following the advent of gene cloning methods during 1970s. It was 
observed that human and murine both IFN had a set of molecular species or 
subtypes and was designated by numerals IFN a-1, IFN a-2. Both the human and 
murine natural IFN-a had 189 a.a., 188 and 190 a.a. respectively. The appeareht 
molecular weight of human IFN-y ranges from 16000 to 27000, whereas the mu 
IFN around 20,000 (Kelder at al 1986). The amino acid composition are similar and 
are rich in glycine and glutamic acid/glutamine. Murine IFN-a Is only 40% 
homologous to their human counterpart. This means there is considerable species 
preferences in biological activity. The species preference are highly active in bovine 
cells. Genes for human IFN subtypes have been shown to be clustered together 
and located on the short arm of chromosome '9' (p22-p13). The equivalent site for 
murine IFN-a 'gene' in mouse is chromosome 4. All of the IFN-a genes are 
intronless which is quite unusual among the cytokine genes, except IFN-p (Arai K 
1990). 
OP 
This is fibroblast interferon, human IFN-p is not much heterogenous and 
often referred to as IFN-p1. Rather unfortunately the IFN-p2 was used to describe 
what was thought to be a second type of IFN-p the eventual molecular cloning of 
cDNA of this cytokine has revealed that it has only very weak sequence homoiogy 
to IFN-p but has sequence identity with BSF-2 subsequently renamed IL-6. Human 
recombinant IL-6 (formerty IFN p-2 or BSF-2) in comparison with human 
recombinant IFN-p and indeed with other IFNs in general has very low antiviral 
(8) 
activity and its claim to be I FN, is therefore, slight. TTiere are however, in other 
species eg bovine multiple subtype of IFN-p shares a high degree of sequence 
homology and are called as pi,p2,p3. Murine IFN-p was originally purified to 
homogeniety from L929 cells. Two forms of mu IFN-p have been identified with 
apparent molecular weight approximately 35000 (class A) and 26000 (class B) 
Both appear to be glycoprotein (Pestk, et a! 1987), mu IFN-p 'A' has 161 a.a. and 
contains three potential 'N' linked glycosylation sites. It is about 60% homologous 
to human IFN-p but there is no cross-species reactivity. The human IFN-p contains 
166 a.a., is preceeded by a 21 a.a 'n' terminal singnal sequence and show only 
29% homology with Hu-IFN a-2 i.e out of 166, 118 different amino acids. The 
genes for human I FN is a single gene that also, is localed on chronosome no '9'. 
IFWy 
Lymphocytes in response to plant lectin such as PHA or Con. A, can 
produce I FN species It was demonstrated in late 1960's and the name of I FN was 
given IFN-y (Meager 1990). The antiviral activity of this IFN was substanically 
reduced following treatment at pH-2. This distinuished it fi'om acid resistant and 
virally induced IFN sources of IFN, includes Th-1, PBMC or splenolytes, IFN-y 
molecules varies between 20,000 to 25,000. This variation is due to glycocylation 
difference of a singale polypeptide species. Upon gel filteratlon natural human 
IFN-y yields an apparent mol. wt. of 40,000 to 60,000 thus suggesting that under 
physiological condition IFN-y exixts as dimer and the functional unit Is a tetramer 
(yip et al 1982, Braud 1984, Braud 1986). Human IFN-y gene is specified by 
unique gene containing three introns located on chromosome no, 12. it contains 
little or no homology with either IFN a or p. 
Interferon a and p genes exist in most of the vertebrates where as the 
IFN-y gene in nonmammalion vertebrates has not been reported (Wilson et af 
1983).Expression of human interferon is performed in E. Coli host very efficiently. 
Most of these interferons in clinical trial are non-glycosylated. The glycosylated 
forn of interferon can be obtained only by expressing the IFNs in animal cells or 
yeast cells. 
(9) 
A structrual analysis of the carbohydrate chain of human IFN-y produced in 
Chinese Hamster Overy<CHO) cells has been reported (Mutsaers 9t al 1986). 
IFN - RECEPTORS 
Interferons exert their action through cell surface specific receptors 
(Friedman, R.M., 1967), was established through several lines of experimentation 
with the invariability of purified IFN development of method of radiolabelling then by 
iodination and phosphorylation more direct studies of IFN receptors became 
possible. Because of non availability of purified interferon receptors, studies have 
largely been confined to human and murine system. Binding of IFN to cells have 
been studied in both murine and human systems with a wide variety of cell types 
(Aguet & Blancard 1981, Branca & Baglioni 1981). Binding at 4^ c reaches 
maximum within 2 I/2 hrs, binding at 37^ C is more complex (Aguet M 1980, 
Branca et al 1982 ). TTie trypsin or diluted acid at 4^ C eliminate surface bound 
interferons. Most of the IFN bound at 4O C are surface bound whereas the amount 
of IFN bound at 37^ C that is,insensitive to trypsin or acid increases the time 
suggesting intemalization. Binding site varies in human, murine and bovine cells 
have also been visualised by E.M. (Zoon KC et a/1983). 
Binding of receptor is saturable and in general 2x102 to 6x10^ receptors 
are reported to be present in one cell characterised by a dissociation constant 
1x10-9 to 1x10-1'' M. There are relatively small number of high affinity receptor 
(Branca A.A. 9t al 1982). It is worth noting that the binding of human IFN to bovine 
cells nearly approaches saturation (Zoon K.C. et al 1982). So that the majority of 
recptors on these cells are indeed high affinity. Human IFN-p does not bind to 
bovine cells but the IFN does (Zoon K.C. et al 1982). 
IFN oc/p receptors 
Genetic linkage to human chromosome 21 to sensitivity of IFN-a and p is 
well documented both in somatic cell hybrid and in cells differing their complement 
of chromosome 21 (Slate & Ruddle 1981). An antibody raised to human mouse 
(10) 
somatic cell hybrid containing human chromosome 21 inhibited the action of human 
I FN (Slate & Ruddle 1981). It has therefore been concluded that gene for IFN oTp 
receptor is situated on human chromosome 21, Experiments with hamster mouse 
hybrid have established that the murine gene is on chromosome 16. In both 
species the IFN-a receptor gene is syntonic with superoxide dismutase (Cox, et a/ 
1980). 
Binding of interferon to its receptor appears necessary but not sufficient for 
cellular activation. Experiments demonstrating that IFN o^p microinjected into the 
cells fails to inhibit the VSV replication, suggest that entry through the receptor is 
required (Higashi & Sokawa 1981). No major contradictory results have been 
reported with IFN-oc, however it was found that mouse cell could be activated by 
human IFN-y that was delivered via liposome (Fidler 1985). In considering these 
apparently contradictory results it is possible that specific internal compartm-
emtation of IFN is cruical to act internally without receptor. Alternatively it is 
possible that the introduction of IFN to the cells by these mechanism may provide 
enormous local concentration that may overcome that species barrier. Yet another 
possibility is that once the IFNs are in cytoplasm their mechanism of cell activation 
or nuclear activation become different in different types of IFNs. 
INTERFERON y RECEPTOR 
Most workers have reported 1,000 to 10,000 receptors per cell with 
dissociation constant 10x10"^ 1x10-11 fj\ (Sarkar & Gupta 1984, Orchansky 
1986). to macrophage. Although the IFN-y is macrophage activator factor (MAF) 
macrophages or macrophage like cell lines do not have distinctive parameter for 
binding with IFN-y although most cells tested have IFN-y receptor. 
The species specificity of IFN-y resides in the interaction of IFN-y with its 
receptors. Human IFN-y does not superficially bind with mouse, hamster or bovine 
cell (Langer et a I 1986). The chromosome location of the gene of human IFN-y 
receptor is some what contradictory, eariier it was contemplated on human 
chromosome no 6., Since this alone was sufficient to protect the cells from VSV in 
mouse and human. Fellovs and co-workers, later indentified chromosome 18 as 
(11) 
the bearer of IFN-y receptor. However it has been envisaged that two components 
encoded by chromosome 6 p and 21 are necessary and sufficient to generate a 
functional IFN-y receptor.No such decrepancy stands in the case of murine IFN-y 
receptor which is reported on chromosome no. 10 (Pestka et a/1977). 
INDUCTION OF IFN 
By a lot of factors a normal cell can be stimulated to produce interferon 
(See Table A & B), This encampasses only a simplistic view of interferon induction 
and production. Sevral cell type respond to different stimuli by producing a mixture 
of Interferon for instance virally induced human diploid fibroblast cells produce 
mainly human IFN-p but, may also produce IFN-a or IFN-y depending upon the 
stimuli, for example T-lymphocyte produce mainly IFN-y following mitogenic or 
antigenic stimulation but if these cells are virally infected these may produce IFN-a 
and/ or p. It should be noted that other cytokines eg. IL-2 or TNF may be co-
produced with I FN in response to common stimuli. 
Besides normal cells a range of tumor derived cell lines are known I FN 
producers for example paramyxoviral infection (Sendai virus) of human B 
lymphoblastoid cell line, Namalwa, induces the production of a mixture of IFN-y 
subtypes and minor amount of IFN-p. This mixture is often referred as 
•Lymphoblastoid I FN". The osteosarcoma derived fibroblast cell line MG 63 has 
been found to be good producer of IFN-p following induction viflth poly l:C or virus It 
is likely that nature of I FN produced by normal or tumor cells is subject to genetic 
control wich influences the transcription of I FN mRNA and post translational 
modification to IFN protein (Torrence and De Clarcq 1977, Pestka 1987 ). 
Normally IFN-y and IFN-p genes are not expressed however induciblity 
appears to reside in the IFN genes themselves. Since when a human IFN gene 
transferred into a mouse cell where it integrates to mouse genome and remains 
inducible by viruses. By examining various IFN gene constructs, DNA sequences in 
5' non coding region have been delineated which appeares to control inducibility. 
These are called interferons gene Regulatory Element (IRE). It is probable that 
(12) 
IRE is an enhancer and similar to those found in other cytokine genes which 
operate in responce to direct binding to nuclear transcription factors. It is thought 
that upon induction two repressor proteins removed from positive response 
domains in the 5' norvcoding region folilowed by association or binding of nuclear 
transcription factors. The second of which may be identical to NFkB for which 
potential binding sites are present in a number of genes involved in immune 
responce and which allow I FN mRNA transcription to proceed (Goodbourn et a/ 
1985, Zinn K & Maniatis Y 1986, Good-bourn et al 1986). 
Although there are many I FN inducers eg. Viruses, double stranded RNA 
(ds RNAs) growth factors (Cytokines), poly IC;LC, 6-MFA etc. The signalling 
pathways and the molecular mechanism leading to I FN gene transcription are not 
known. However the fact that the dsRNA, in itself ( which is an Intermediate in viral 
genome replications of RNA viruses) is able to induce I FN genes expression 
suggests that dsRNA is a " Proximal inducer". The question that remains whether 
the double stranded RNA interacts with the respressor proteins bound to the I FN 
gene, IRE or with nuclear transcription factor elements in gene, IRE or with nuclear 
transcription factor elements in the cytoplasm. There is not yet any unambigous 
evidence to answer this. It is also not clear whether dsRNA is unique as a proximal 
inducer or whether their are other molecules which could perform the same 
function. 
Following induction transcription of I FN mRN continues for a brief period of 
few hours before the I FN genes are fully shut down again. The reason for this 
renewed repression is unknown. Trancription of I FN mRNA, particulatly IFN-p may 
however be enhanced by blockers of the protein synthesis such as cycloheximide. 
The simplest explanation of protein synthesis curtails the production of I FN gene 
repressor proteins, although cycloheximide may also stabilize IFN-p mRNA in as 
yet unknown way ( Meager, 1990). 
Virus infection in mouse cells induces IFN-a and p Poly ( I ) Poly (C) on the 
other hand induces essentially only IFN-p (Cavaleiri R.L. et ai 1977). An enhancer 
element inducible by Poly ( 1 ) Poly (C) is located between -77, -37 from the 
(13) 
mP.NA cap site and can function upstream or down stream of IFN-p gene at a 
distance upto one Kb (Goodboum et af 1985) Studies reveal that repressor 
molecules are released by induction and tlien transcription factors bind to the 
region located between -77 and -64 (Zinn., Maniates 1986 Goodboum et al 1986). 
These results indicate the negative regulatory mechanism controlling the 
expression of IF^4-p. 
STATOLON 
Statolon as found by klinschmidt and Murphy (1967), is effective non viral 
inducer of I FN. The treated animals were shown to resist challenge infection by 
MM virus and stay refractory that way for at least 30 days if the inducer was given 
by the transperitoneal route, ds RNA was identified as the IFN inducing component 
in statolon that originted fi'om virus like particle carried by the fungus strain ATCC 
1486 (NRRL 5267) of Penicillum stoloniferum. (anks et a/ 1968) between the 
period of 1957 and 1975, over 65-fungal species were identified to be the source 
for production of broad spectrum antiviral agent all double stranded RNA. The chief 
ingradient responsible for induction of interferon besides P. stolniferum, 
P.funiculosum and P. chrysogenum are other two fungi known for their ability to 
produce IFN inducers as efficient antiviral agent effective in stopping vertebrate 
virus infection. 
POLYIC:LC 
The synthetic double stranded RNA Poly riboinosinic Poly ribocytidylic acid 
(Poly I Poly C) is effective in rodent and rabbit as an interferon inducer (Field et af 
1967) as an antiviral agent both prophylactically and thereputically (Parks and 
Baron 1968, Worthington et a/1973 ). Affter extensive toxicological studies it was 
tested in man and the results were disappointing Poly (I) Poly (C) shows very 
weak capacity to induce IFN in man and other primates. It had no demonstrable 
antitumour action (Young 1971) that man was not totally unresponsive, was shown 
in experiments in wich Poly I Poly C was given to volunteers prior to infection with 
rhinovirus or influenza virus (Hill et al 1972). There was statistically significant but 
(14) 
not dramatic protection. It was demonstrated that Poty D-lyslne enhanced the 
action of low mol. wt. Poly ( I ) Poty (C) (Rice et al 1971). Serum interferon activity 
was measured in monkey after Poly IC:LC treatment once daily for 10 days. From 
0,1 to 6.0 mg/kg it was found that interferon activity was detectable after +2 hrs. 
of first injection and was maximum at +8 hrs. after the second injection. A period of 
hyporesponslveness occured after the third injection of Poly IC:LC and continued 
till 6th injection. A rebound was observed in rhesus not cynomolgus monkey. No 
any, side effect was observed up to 6mg/kg dose treatment (Sammons e^ al 
1977). One possible explanation for the difference in dose response during the 
hyporesponsive phases and subsequent increase in interferon activity in the rhesus 
monkey is that some population of new cells normaly being produced in monkey 
could be induced to produce interferon by the higher doses of poly IC:LC other 
possible interferon control mechanism is, circulating refractory respressor 
products, which If depleted by repeated injection of interferon inducers could also 
result in interferon activity in the higher dosage group and in the recovery phase 
reported in rhesus monkey ( Stringfellow 1972 ). 
6-MFA 
A mould filterate designated 6-MFA was produced from a laboratory strain 
of Aspergillus flavus and primarily reported for anti Semliki Forest Virus (SFV). 
The product was an Acetone Fractionated Mycelia. (Chandra, Maheshwari and 
Gupta 1971). It is a pale white to chocolate colour thermolablle, seitz filterable, 
non dialyzable and sedimentable showing a virus like particle under electron 
microscope ( Maheshwari et al 1973 b) constituents of 6-MFA are polysaccharides 
and nucleoprotein ( Virus like particle ). The dsRNA components are consist of at 
least four mol.wt. fragments varying from 0.74 to 1.08x10^ dalton ( Kong et al 
1979 ). First antiviral from Aspergillus species was reported as early as 1970 
( Banks et al 1970 ) where it was considered that it was a virus dsRNA from the 
fungus which led to the induction of antiviral activity. The 6-MFA was tolerated by 
animals well beyond 300 mg/kg and the protection vwis observed only among the 
(15) 
animals that were treated 24 hrs prior to the viral inoculation. Although the 
mechanism of immunity in mice induced by 6-MFA was not known it was 
suspected that it might be protecting mice from SP/ via interferon induction 
( Maheshwari R.K. and Gupta B.M. 1973 a). 
In combination therapy of 6-MFA with cyclohexamide it was observed that 
cyclohexamide, at 56 mg/kg enhanced the effect of 6-MFA (14 mg/kg) from 25% 
to a maximum of 87%. ITie combination was however toxic at a dose of 117 mg. 
(Maheshwari R.K and Gupta B.M 1973 c). 6-MFA was confirmed as IFN inducer. 
Unlike Poly IC:LC it was obrseved to induce both the type I and type II interferon 
(SinghV.K. e(a/1983). 
Most of the acid labile interfems may be IFN-y was suggested from 
experiments on neutralization of antiviral resistance inducing activity of 6-MFA by 
administration of mixture of a and b antisera alone under conditions which permit 
complete neutralization pf activity of Poly I.C would account for only part 
abrogation of activity of 6-MFA (Gupta B.M. and singh V.K. 1984). Other effects 
of 6-MFA that are not pleasant includes excessive depletion of tissue 
prostaglandins ( PG F2 a and earty death of treated animals (mice) In presence of 
sub toxic dose of antinflammatory drugs such as indomethacin (Singh V.K. et at 
1981). The immunomodulatory action of 6-MFA in mice was demonstrated fr^ om 
observations that it suppressed red blood cells antibody response if administerde a 
day before the antigen but stimulated it if the inducier was given two hrs, after the 
antigen treatment (Singh V.K. et af 1983, Singh V.K. et af 1984). All the interferon 
inducing agents have a suppresive effect on hepatic cytochrome P-450 wt>ich Is 
considered to be an antitoxicant and stimulates the degradation of drug or toxins if 
activated thus IFN inducer may have profound effect on the toxicity and therapeutic 
actiNoty of the drugs ( Mannering et a/1980 ). 
Immunomodulatory effect of interferon and interferon inducers are not 
always similar, indicates that the interferon inducers play differently for a given 
immune phenomenon. Interferon blocks the glycoprotein-factor that stimulates the 
production in agar of granulocyte macrophage colonies whereas, Poly I Poly C, 
(16) 
both in vivo and in vitro stimulate such activity. That is, even though Poly I Poly C 
leads to the production of interferon which is a colony inhibiting substance the 
stimulating activity of dsRNA itself overcomes such inhibition ( Levy et af 1980 ). 
MALARIA WITH INTERFERONS AND INTERFERON INDUCER 
Malarie has the higest incidence among the various parasitic diseases and 
is gratest killer of infants and children. It is an incapaciating desease of highest 
order among the adults of the tropical and sub tropical region of the world with 
300-500 million clinical cases and 1.5 to 2.7 million death per year and 90% of 
them in Africa ( TDR News 1994 ). A WHO estimation states that 2.7 billoin people 
live in the area endemic to malaria ( TDR News 1991 ). 
Because of under reporting or under detection accurate frequency of the 
disease can not be reported. In India malaria has been one of the most sarious 
and persistant public hetth problem. Even after malaria eradication programme the 
incidence has been increasing and is approximately 1.5 to 2.5 million cases 
recorded every year. From species of genus Plasmodium which causes malaria in 
human being are P. falciparum P. vivax P. malariae and P. ovale. Out of these 
our P. falciparum is the greatest devil and is responsible for 85% of total cases of 
malaria worid wide (WHO Bull, 1981). Followed by P. vivax other two have 
relatively sporadic incidences and only patchy foci . In India the scenario is not 
much different, 60% of the total cases of malaria are because of P. falciparum 
and P. wVaxis next parasite (IMCR 1994). 
In experimental model of primate malaria P. Knoweisi and P. cynomolgi are 
major parasites P. cynomolgi can be compared with P. vivax of human parasite. In 
rodents the malaria is caused by many Plasmodia species that includes P. yoelii. 
P. berghei, P. vinckei and P. chabaudi. P. bergflf^and P. yoelii are more readily 
transmitted in the laboratory than the vinckie group (P. vinckslkor P. cti^baudi). 
P. yoelii can also very easily be transmitted by mosquitoes as P. berghei. Both 
are studied in white rat or hamster. Anophelese stephensi is the most satisfactory 
(17) 
mosquito for labortory transmission of all these species of rodent malarie. 
Granulotocyte production is equally good in hamster mice or rat. 
Drug resistance in malaria has been the greatest problem for the treatment 
of the disease. It was reported for the treatment of the disease. It was reported 
for the first tihie during the first world war (1914-1918) when quinine failed to cure 
many cases of malaria in both sides. In experimental P. /?ergf/7e/quinine resistance 
was reported in 1965 by Jacobs. Now malaria parasites have developed 
resistance against almost all the existing antimalarials (Peters 1967). The search 
of new therapeutic aveneues in malaria attracted spontaneously the immunono-
dulators with great hope. Cytokines the latest reported member at the arena of 
immunomodulation were the obvious choice. Many cytokines including various 
interieukines and interferons have been studied in diffrent stages of malarial 
infections. 
The efficacy of endogenous interferon produced during malarial infection 
has been investigated against Plasmodium chabaudi AS and found that the peak 
interferoiVY production occure just before and at the peak parasitaemia. The 
monoclonal antibidy against this pluripotent tymphokine was treated in blood stage 
infection and was found that the IFN-y mAB impairs but not completely abrogates 
the host resistance to P. chabaudi AS. (Stevension M.M. ©f a/ 1990). Inhibitory 
effect of I FN is also reported in exoerythrocytic stage Plasmodium fafcif^um in 
individuals (Deloron P. et al 1991). A specific DNA probe was developed to study 
the effect of recombinant-y, interferon, of mouse, rat and human origin and was 
observed that only exoerythrocytes were inhibited not the erythrocytic forms, it 
was further observed that the treatment, a few hours prior to the inoculation of 
sporozoite inhibited the sporozoties (upto 90%). The treatment beyond 18 hrs 
preinoculation or a few hrs post inoculation of sporozoite inhibited the sporozoites. 
Human I FN also diminished the paraistaemia in chipanzee with P. vivax infection at 
15 nanogram of protein (Ferreira A. ©J a/ 1986). In interspecies activity the 
recombinant human IFN-y has been shown to be valid in the case of P. cynomofgi 
infected rhesus monkey where, it suppressed completely the sporozoite inoculation 
(18) 
at 0.1 mg/kg body wt. of IFN-y per day from -1 to +13 day (Maheshwari et a/ 
1986). Lymphokines generated from chronically infected monkey with P. knowlesi 
or P. cynomol^i can activeate the blood derived monocyte (BDM) and splenic 
macrophages for enhanced phagocytosis of intraerythrocytic (IE) stage parasites 
in vitro. (Singh P.P. and Dutta, G.P. 1989). In the similar experiment with IFN-y it 
has been demonstrated that lymphokine activated murine macrophages against the 
rodent parasite via extra cellular secretion of oxygen intermediate specially H2O2. 
This killing intiated by an oxidative brust which may be triggered by the 
phagocytosis of parasitised erythrocytes and enhanced by small amount of 
hyperimmune serum. (Ockenhouse C.F. et a! 1984). 
In a freshly twist, it has been investigated and suggested that IFN-y on P. 
berghei infected hepatocyte induce the production of L. arginine derived nitrogen 
oxide (NO) that is toxic to the intracellulat parasites. Depletion of L. arginine by 
treatment of arginase to culture medium blocked the capacity of IFN-y to inhibit the 
parasite devlopment in hepatocytes (Mellouk S et al 1991). 
Three IFN inducers, statolon, Newcastle Disease Virus (NDV) and Polyribo 
inosinic. Polyribocytidylic acid (ri:rC) were investigated in case of sporozoite 
induced P. berghai infection. The result extended the spectrum of interferon 
Inducer in protozoan P. berghei. They demonstrated a protective effect of 
interferon inducers in murine malaria, and suggested that the protection is 
mediated by IFN. Serum interferon (mostly type I), after induction by NDV and 
without purification was given into the mice with P. berohei infection at various 
intervals. The result showed that mouse serum with interferon exerts a significant 
protective effect after the parasites enter into erythocytic phase I.e. the treatment 
after 45 hrs of the sporozoite infection. It was further inferred that the rabbit 
interferon induced evaluated in similar fashion showed no dffect on the mice 
malaria (Jahiel R.I. et af 1970). 
6-MFA from Aspergillus ochraceus has been reported to enhance the MST 
significantly when treated in three multiple doeses on - 1 , +4 and +8 days. This 
much effect was however not observed in other dose schedule of product 
(19) 
(Yadava J.N.S. et al 1983). The effect howerver varied when the animal were 
treated from -4 to +7 days without significant increase in MST (Rizvi M.A. ef al 
1994). Suppressive effect were observed on sporozoite induced P. yoe/// 
interferon In mice (Rizvi M.A. et al 1995). Lysine conjugated poly I.C., potent 
inducer of interferon type I (mianly p) protects completely at a single dose of 1 
mg/'kg If given 24 hrs before the sporozoite inoculum ( Maheshwari et al 1993 ). 
The drug resistance reversal efficacy was evaluated in diffrent regimen 
against the multl drug resistant P. yoelii and was found that some of the batches 
gave a significant result when treated in combinated with 6-MFA (Rizvi M.A. 
unpublished ). 
TABLE - A 
S.N INDUCERS STIMULATED CELL TYPE 
1. Viruses eg. NDV.VSV 
2. Duoble stranded RNA,Poly I:C 
3. Endotoxin, eg. Bacterial LPS 
4. Poly carboxylate 
5. Low mol. wt. compound eg. Kanamycin 
6. T or B lymphocyte stimulating agents eg.PHA 
Con. A 






Torrence and De Clercq ( 1977 ) 
(20) 
TABLE - B 
IFN Type AJternative Name Major Producer cells Stimuli for production 






Null Lymphocytes Monocytes, Viruses, Bacteria,Xe-
Marcrophages nogenic or Allogenic 
tumor cells. Virally 
infected cells and 
B cells Mitogens 
Fibroblasts, Epithelial cells Viruses, polynucle-
otides 
T Lymphocytes NK cells Allogenic cells or vi-
rally infected syng-
eneic cells Foreign 








Swiss albino mice, Mus musculus, of either sex were procured from 
CD,R.I. Animal breeding and supply center. Animals weighing 14 -15 gm (about 
35 days old) were taken for viral studies and around 20 gm for malarial infection. 
These animals were tested for any possible infection and were supplied with 
standard food. Kept in ventilated room with regulated temp of 35® C. The rooms 
were illuminated with fluorescent tubes from 7.00 A.M to 7 P.M in order to obtain 
12 hrs photoperiodicity. 
II. PARASITES 
Plasmodium yoefii negehensis was maintained in swiss mice from the 
available multidrug resistant strain stock. The drug pressure, with chloroquine was 
regularly kept in the serial blood passages. Due to prolonged blood passages, the 
strain has lost the gamete producing capability and essentially require blood 
passages. Another Plasmodium yoelii nigeriensis (London strain) that was 
sensitive to various antimalarials and produced gametocytes unlike the resistant 
strain, was procured from Malaria Research Centre (MRC) New Delhi and was 
maintained through cyclic passages in Anophelese Stephens! and Hamster. When 
the hamster blood was positive for gametocyte (Day 6-8 post inoculation). The 
mosqutoes were allowed to feed on it and were maintained in Insectary at 27±1 "C 
and 78-80% relative humidity. Mosquito midguts were dissected out and observed 
for the persence of oocysts on day +6. After 10 days of initial feeding, oocysts 
brust and sporozoites migrate into salivery gland. When the mosquitoes were 
found positive for sporozites the infection was transmitted into naive animal either 
through the direct mosquito bite or through the 20% serum supplemented saline 
containing the harvested sporozites. The inoculation performed via tail vein of the 




Acid Citrate Dextrose ( ACD ) was prepared as under-
Citric acid Anhydrous 730 mg 
Trisodium Citrate 2200 nng 
Dextrose 2450 mg 
Dist Water ( up to ) 100 ml 
The final solution was autoclaved at 15 Lb/inch2 pressure for 15 minutes. 
IV. STAiW 
Giemsa stain (Either from the ready made bottel BDH 20% concentration in 
phosphate buffer or from the ingradients). 
powdered stain (sigma) 1gm 
Glycerol 60 ml 
Methyl Alcohol (Absolute) 60 ml 
The powedered stain and glycerol were grinded together to from a paste 
and dissolved in glycerine both at 55-60^ C for 60 minutes. After cooling methyle 
alcohol was added and mixture was allowed to stand for two to three weeks then 
filtered for use. 
V. PHOSPHATE BUFFER 
The stock solution for the staining buffer were preprared as given below. 
51 - 9.5 gm Na2HP04 in 1000 ml Distilled water 
52 - 9.0gmKH2PO4 in 1000 ml Distilled water 
working soln was prepared by adding 72 ml of S1 and 28 ml of S2 to 900 
ml distilled water. The pH of resulting soln was adjusted to 7.2. 
(23) 
VI. INITIATION OF INFECTION 
(a) Blood Induced Infection 
Animals were infected intraperltoneally with parasitised RBCs taken either 
from cryopreserved samples or from the fresh blood of previously infected 
animals taken in anticoagulent (ACD). Standard inoculum consists of 1x10^ 
parasitised RBCs per ml, 
(b) Sporozolte Induced Infection 
It was initiated using 1x10^ sporozoites per mm^ and injected intravenously 
through tail vein. The sporozites were taken from regularly maintained cyclic 
passage. 
Thin blood smears of mice were prerared by cutting the tail edge with 
Scissor or pricking it with the help of lancet. The blood films were made on clear 
microslides and stained with Giemsa stain according to the standard protocol 
(Russel et al 1963 ), 
VII. ENUMERATION OF PARASITEMIA 
Parasitemia was expressed in percentage of RBCs infection or number of 
parasitised RBC per 10^ RBCs. When the parasite count was too low 
(on day +2/3 ) the slides were observed under oil immersion to detect any patent 
parasitemia and if no parasite was seen in the 200 fields of the thin smear the 
slide was declared negative 
VIII. CULTURE OF Asperaiflus Ochraceus FUNGI 
Aspergillus ochraceus fungal strain A1CC-28706 was provide from the 
existing lot of Microbiology division CDRI (Courtesy Dr. C.X. George). It was 
cultured in Shope media at 26±lOc under B.O.D. incubator. The culture was 
performed in one litre capacity flat bottom flask with 150-200 ml media into every 
flask, pH was adjusted to 7.2 and sterelity was ensured in culture room. This 
species of Aspergillus is not as dangerus as the A. flavus which causes 
Aspergillosis, however, precaution was made to avoid any possible inhalation. The 
culture was terminated on day 7 to 8 before the dense spore formation. The 
fungal mat processed to get the I FN inducer 6-MFA. 
(24) 
IX. COMPOSITION OF SHORE MEDIA 
Potassium dihydrogen Phosphate (KH2PO4 ) 1gm 
Potassium chloride ( KCI) 0.5gm 
Sodium Nitrate ( NaN03 ) 3.0 gm 
Magnesium sulphate ( Mg SO4 ) 0.5 gm 
Ferrous sulphate ( FeS04.7H20 ) 0.01 gm 
Glucose ( CeHi206 ) 40 gm 
Yeast extract 10 gm 
Zinc Sulphate ( ZNSO4.7H2O ) 0.001 gm 
Sodium Potasium Tartarate 0.01 gm 
the constitunents were dissolved into triple distilled, water to get the final 
volume to 1000 ml. 
X. VIRUS 
The Semliki Forest Virus (SFV) was obtained from the pre-exslting stock of 
Dr. C. X. George., Microbiology division CDRI. It is lethally pathogenic for white 
mice. Brains of interacerabally infected young mice weighing around 7-8 gm with 
the full blown symptoms. The brain homogenate was prepared for taturation in 
Hank's Balanced Salt Solution (Hi Media HBSS) pH 7.2 The solution was 
centrifuged af 4° C and superantant at the volume of 0.5 ml/mouse brain was 
dispensed into sterile capped vials and stored at -20^ C or frozen 002- From 
amongst the stored vials, one was serially diluted to calculate the 50% lethal dose 
(LD50) of virus which generally varies between 10-5 to ^0-^ dilution of infected 
brain. The dilutions were made just prior to the inoculation and were kept in ice 
bath during the time of administration into the mice. Viruses were admlmistered 
subcu-taneously at a dose of 10 to 100 LD50. Mice dying in first 48 hrs were not 
included in the experimental results. All the mice where observed twice daily for 
14 days. 
JU iXd ^SU C!^  JU kX^  JU ^lU ^lid iSU iXd t^^ JU Jj iSU d^ ^1^ JU JU JU JU ^Su JU iXU f3^ ^j^ ^j^ rj^ r]^ fj^ ^1^ r^ r]^ r]^ rj^ rj^ ^ j ^ J^^  rj^ fj^ fj^ ^/^ ^jH} fj^ ^j^ rj^ fjl^ Pj^ 
RESULTS 
J ^ iSU J^ J^ CTj J^ J^ LT^ ^T^ ^f^ ^ I ^ kT^ kTi CTJ CTJ J^ J^ ^TJ kTi LTJ ^f^ CT4 Cf^ CjTj 
(25) 
PRODUCTION OF 6-MFA 
For the production of 6-MFA. Aspergillus ochraceus was cultured in shope 
media at 27° C in BOD incubator under stationary flask culture method after 8-9 
days of the fungal culture growth was enough in each flask Which was nnixed 
properly in the media left in the falsk with the help of mixer. Now the solution was 
centrifuged at 2000 rpm for 20 minutes and the supemantant was saved. This sup 
was mixed in chilled acetone. The volume of acetone was equal to the volume of 
Shope media intially taken for the fungal culture. This mixture was left at-200C for 
24 hrs, Next day the solution was again centrifuged at 2000 rpm for 20 minutes. 
This time superatant was discarded and dissolved in appropriate amount of sterile 
double distilled water and was incubated at 4^0 for overnight. This solution also 
was centrifuged at 2000 rpm for 20 minutes and this time pellet was discarded, 
and supernatant saved. This supernatant was dispenced into sterile beakers. The 
solution was stored in deep fridge, at -200Cand next day it was tyophilised till the 
solidification of the product. Vacuum dried solid was scratched from the beakar 
and was kept at room tempatature as the final product is highly hygroscopic. 
ANTMRAL ACTIVITY 
Different batches of 6-MFA were prepared at Microbiology division and 
fermentation technology division CDRi. These batches ware evaluated against 
Semliki Forest Virus (SFV) Out of all the tested batches only M I and M II 
(batches prepared at Microbiology division) were found to be 100% protective 
against S.F.V. FT-A, FT-B and CXG batches were all Siqulficant against control 
with protection level 40% 50% and 62.5% respectively (Table I). The virus 
inoculum was given after two splitted doses of 6-MFA at -24 hrs and -7 hrs 
through i/p route. Animals protected by 10 LD50 of virus inoculum remained heathy 
till 28 days of observation, when the protected mice rechallenged w^hlOLDsodose 
of SFV further showed no protection against SFV as all the animal died with MST 
5.4 ± 0.55 ± 0.24 as compared to the control, MST4.67 ± 0.57 ± 0.34 
(26) 
The M II batch of 6-MFA at various dose schedules like 100 mg/kg body 
wt X 2 (-24 hrs and -7 hrs). 50mg/kg b.w x 2(-24hrs and -7hrs) and 100 mg/kg b.w 
X 1 (-24 hrs). The obsen/ation made on 100 mg/kg body weight revalidified the 
earlier result of 100% protection by this dose schedule, while the other two 
experimental groups displayed a partial protection of 20% and 37.5% respectively. 
The MST of 100 mg/kg x 1 was 10.5 ± 0.71 ± 0.5 appeared highly signficant as 
compared to 4.86 ±1.21 ± 0.46, the MST of control group. The 50 mg/kg b.w 
group had the MST 6.67 ± 2.08 ± 1.2 (table II ). 
ANTIMALARIAL ACTIVITY 
Both the P. yoelii and P. berghei, rodent malaria parasites were taken for 
the evaluation of blood schizontocidal efficacy of 6-MFA batches. M II batch of 
6-MFA was evaluated against fiasmodium berghei at 100 mg/kg body weight in 
three multiple doses on days - 1 , -i4 and +8 Appearently the results were not much 
encouraging only 16.66% protection was found with slightly elevated level of MST 
that is, 17.0 ± 1.4 days as compared to control group wliich had 16.33 ± 2.33 
(table III ). 
M I & M II, the most active batches against viruses were taken to evaluate 
their blood Schizontocidal profile against P. yoelii nigeriensis. The MST was found 
to be significant when analysed versus control with 7.29 ±1.5 ± 0.57 and 6.63 ± 
0.92 ± 0.33 days for Ml & M II group respectively the MST of control group was 
5 ± 0.76 ± 0.27 days. The treatment was given at 100 mg/kg body wt. from -1 to 
+5 days (table IV ). 
Other batches of 6-MFA were also evaluated at various dose regimen 
against P. yoelii nigeriensis blood stage parasite FT-1 and FT-2 were treated at 
lOOmg/kg from -1 to +5 days where as FT-3 and FT-4 were treat at 50 mg/kg 
body weight from -1 to +5 days The MST in FT-2 & FT-4 appeard highly 
siqnificant when compared with the control, which had 6.3 ± 0.51 days while the 
FT-2 was 9.33 ± 0.51 days and 8.2 1.0 days for that of the FT-4. The FT-1 and 
FT-3 batches of 6-MFA although, were treated at different dose schedule the 
(27) 
mean survival of these two batches were very much in accordance with each other 
that is, 7.5 ± 0.54 days for FT-1 and 7.6 ± 0.51 for that of the FT-3 batch of 
6-MFA (table V). 
The antimalarial spectrum of S-IWFA as shown under the results 
demonstrated a partial antimalarial activity of 6-MFA against P. yoelii as shown 
by extension of mean survival time (MST) while activity against P. berghei was 
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ASPERGILLUS OGHRACEUS FUNGAL CULTURE : FLASKS 
UNDER BOD INUCUBATOR. 
I l l l i l l i l J ] 
~r 1^" 
ASPERGILLUS OCHRACEUS : FULL GROWN CULTURE JUST 
BEFORE HARVESTING. 
CRUSHING AND MIXING OF THE HICELIA IN THE EXHAUSTED 
SHORE MEDIA. 
6-MFA PRODUCT UNDER MNAL PROCESS^ CLYOPH.UZATION). 
READY TO USE : BROWNISH POWDER OF 6-MFA. 
: ^ >d>; >Ll>: :A±ki ^d j t j t l j t aCh; y i fe ^djk: j d v sLps :*+>: jt+A: : i t jk >!+>; ^t±j^ ^rh^ jj-K; ^it^t ^ATV ^ ^ 
>rp« >q> 2i4> >qy ^rpc ^rpt ^rjic i f ^ ir^pf >cp« >rjTt s q ^ ^cp: ^ q y arpc J ? ^ >rj< >rpt >rjic ^rj^c arjuc 
DISCUSSION 
?st< ?CJe >iijc >ifc: jstic >Cbc jCtk; ;i±Jk: :ii±jkr >iik: j t j i : >i±k: j i i i c >+J5 > t i ; ?CL< 5i±i« j i tJ t j i i t sCtU: sd>: 
> + ^ > ^ vpc VSc i f j ^ > f j ^ 3 ^ > ^ > ^ > i ^ > ^ > ^ i f ^ >,q;s > x * ' r j ! ' i rpc >rp«: >fpf >Cp« 3rjT< 
(28) 
With the information that the virus colonized cells in animals or in culture-
dish interfered with the ability of other unrelated viruses to establish infection at 
the same time, Alick Isaacs and Jean Lendenmann showed that a substance, 
secreted by the infected cells was responsible for this phenomenon logically 
enough they named it interferon. They demonstrated the agent as protein. It did 
not interact the viruses directly rather they induced diseased cells and their 
neighbours to make still other proteins that could prevent invading viruses in 
exponentiation of their growth. Since the discovery of Isaacs and Lendenmann 
countless investigators have devoted and directed their study towards interferon 
research. The findings are suprising like the interferons modulate the activity of 
virtuatty every component of the immune system. In so doing, they enchance the 
body's abitily to quell attacks by most disease causing agents including bacteria, 
protozoan parasites and viruses (Pestka S et al 1987). Over the years use of I FN 
and interferon inducers for control and management of viral disease in man as well 
as animals have come up for serious considerations. Different I FN inducers have 
been tried against various viral diseases. In murine rabies virus Poly I Poly C 
(Harmon and Janis 1975) In human Influenza or rhino virus poly nucleotide (Aoki et 
al 1978). and In food and mouth disease virus 6-MFA, have been tried with partial 
success. The polynucleotide inducers of I FN have been reported to reduce the 
symptoms of respiratory tract rhino virus in human system and diminishes the foot 
and mouth disease virus In animals (Aoki F. Y et al 1978). 6-MFA also is reported 
to have a cSnrwiishing effect on foot and mouth disease (FMD) virus in guinea pig 
(Lai SM et al 1980). Upto some extent immunity devlopment against the FMD also 
has been reported after 18 days of primery challenge (Lai et al 1980). IFN 
inducers are found to be good adjuvent against viruses and protect the animals 
better than either vaccine or the inducer alone, if given in combination with vaccine 
(Harmon and Janis 1975). The result shown by us indicate that there is no 
prolonged immunity against SFV as all the animals died on rechallenge (after 28 
days of protection from the first challenge) with mean survival time (MST) 
(29) 
5.4 ± 0.55 days 6-MFA has been taken and tried against various other viruses in 
addition to SFV. At a dose of 175 nng/kg body weight of 6-MFA the results were 
interesting. Semliki Forest Virus (SFV) showed 100% protection while 100% 
aninnals died in control group. Neurovaccinia virus (A pox virus) IHD strain showed 
only 43% protection vi^ th 9% survival in control. Chikungunya and Dengu type 2 
(both encephalites virus) showed 70% and 15% protections respectively and 12% 
survival in the control group of both the viruses. Thus, it may be stated that 6-MFA 
acts differently in different visuses as shown here, 100% protection against SFV 
followed by chikungunya virus and lastly neurovaccinia virus. No antiviral acticity 
was observed against Dengu virus (Maheshwari and Gupta 1973 d). This variable 
result could be due to variation ^ the mechanism of infection of different viruses. 
SFV enters into the cells via chotestrol mediated cell surface receptor . This 
phenomenon is carried out by the endocytotic process and at low pH. Other 
viruses shown here, have not been reported for this kind of mechanism (phalen 
and Kicllan 1991). The likelihood of difference in immune evasion in various kinds 
of viruses can't be ignored It is still uriclear if 6-MFA disrupts the membrane 
cholestrol or creates a temporary pH change in cellular meleue or switches the 
immune system in yet other unknown way. A hinderence or disruption in 
endocytosis through Immunological or Biochemical alterations seems very 
convincing. 
6-MFA prepared by us was produced by stationaty flask culture of 
Aspergillus ochraceus m Shope media Since Shope media produced more micella 
than spores. The other media (Mayer's broth) favoured spore formation. Shope 
media product of 6-MFA proved better since it protected 87% as compared to 
only 60% in Mayer broth (Maheshwari and Gupta 1973 a) Use of shaker for the 
fungal culture also found to be significant when compared to the stationary flask 
culture method in the same media. We found that stationary flask culture in shope 
media protected 100% animal but the shaker, (experiment carried out in rotary 
shaker at 250 r.p.m. for 72 hrs) could protect not more then 62%. This finding is in 
accordance with eariiar report of 87% protection in stationary flask and 70% 
(30) 
protection in shaker culture (Maheshwari and Gupta 1973 a). Route of 
adnninistration was also investigated and it was found that only i/p route is 100% 
protective, s/c route could protect 80% animals. Routes other than these two are 
comoletety failure. (Maheshwari and Gupta 1973 a). Interferon and interferon 
inducers in addition to viruses are evaluated for their possible role against various 
bacterial and protozan infections. The results are again variable mu IFN-y failed to 
inhibit toxoplasma gondii grov4h in murine fibroblast (Schwardzman J.D et a!) 
IFN-y and TNF-a had antiricketsial activity (Feng and walker 1993) Leishmania 
donovani is an obligale intracellular parasite of mammalion macrophages. It has 
been reported that the parasistes increased their infections 3 fold when treated 
with immunosuppressent, cyclosporin A (CSA) This CSA inhibits the productions of 
Lymphokines like IL-1 IL-2 and IFN-y it WQS further summerised that the 
lymphokine control the infection of leishmania (Olivier M. ef a/1989) This has been 
further exploited in the treatment of Leishmaniasis. The IFN-y has been found to 
be useful adjunct therapy for severe and refactory cases of visceral 
Leishmaniasis, however, the potential of IFN-y in treating difdise cutaneous 
Leishmaniasis could not be assessed ckte to limtted ctinlcai experience. (Badaro 
and Johnson 1993). 
Effecacy of (FN has been studied against various piasmodial species. 
Monoclonal antibody against the IFNs ir>duced by piasmodial infection was found 
that It Impaired but not completely abrogated the piasmodial infection. (Stevenson 
MM 1990 ). Inhibitory effect of interferon is also reported in exoerythrocytic stage 
of P. falciparusm (Deloron P et al 1990). Different types of inducers of IFN viz, 
Newcastle Disease Virus (NDV) statolon and polyriboinosinic and potyribocitidylic 
acid (rl:rC) were evaluated for their antimalarial activity against P. berghei in mice. 
Sporozoit infected mice demonstrated that the IFN inducer treated animals 
showed a delay in patency or completely prevented the parasitemia. These 
protective effects were found to be due to serum interferon induced during the 
course of time (Jahiel R. 1969) Our results on P. berghei are in similitude virith the 
above as it has demonstrated 16.66% protection. 
(31) 
Blood schizontocidal efficacy of 6-MFA against multidrug resistant (mdr) 
P. yoelil was evaluated taking the 6-MFA batch which had 100% protective effect 
on SFV. This however, failed to protect or cure the animals but showed a 
significant increase in mean survival time (MST) of the infected animals. The 
finding again, appears to be in similitude with the earlier information (Yadava JNS 
et al 1983) Lack of blood schizontocidal efficacy in other I FN inducers have also 
been reported in mice malaria (Jahiel R. I 1970) The IFN inducer is active in tissue 
schizontocidal efficacy. 
Interferon inducers are found to be good adjuvent against viruses and 
protect ttie animals better than either vaccine or the inducer alone (Harmon and 
Janjs 1975). Application of IFN as the adjuvent in malaria vaccine now Is on anvil 
after the above finding. Protection of mice by deadly P. yoelli infection has been 
reported when vaccination was performed with triton x-100 of whole parasitised 
erythrocytes. The adjuvent used was recombinant IFN-y, dministred either intra 
peritoneally or subcutancously (Playfair and De Souza 1987). 
The mechanism, how IFN and the Inducers kill the Infectious agents Is still 
not completely understood. The avalanche of new information has flattened or 
fr^actured the earlier made conceptual frame-work. Now the Nitric oxide (NO) 
which is an effector molecule and produced from macrophages through the 
constituitive (c) and inducible (i) nitric oxide synthetase enzyme from L-arginine 
molecules is understood to be the main cause of curing or killing the infectious 
egents. IFN-y has been shown to act through this fashion agalnts bacteria in 
murine peritoneal macrophages (Park and RIklhisa 1992). In exoerthrocytic form 
of P. berghei, L. arginlne dependent parasite killing has been demonstrated in 
hepatocytes (Mellouk S et af 1991). Nitric oxide or its oxidatine products are found 
to be killers of the In vitro P. falciparum ( Rockette et al 1991 ) In addition to 
biochemical changes that nitric oxide brings about, genetic alteration in the 
parasite DNA molecule can be the Important cause of death of Infectious agents 
( Nathan C 1992). 
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(32) 
Malaria is still a growing menace throughout the world. It is the disease of 
poors of the world, esperially in tropical and subtropical geographical regions. A 
carefull estimation has stated about 500 clinical cases every year and upto 2.7 
million deaths per year are encountered due to malaria. 90% of these death toll 
are recorded only in African countries. The diseare, once, thought to be at the 
verge of eradication, has lashed back with a vengeance, due to the emergence of 
drug resistant parasites and arthropod hosts at the global arena. Today, this 
resistant strains of malaria parasites is encountered against virtually every 
possible drug available in the market for the treatment of malaria. In India, once 
lesser dangerous parasite Plasmodium wVaxwas prevalent but, now the scenario 
is changed, it has been subdued by the fatal P. fadiparum species which 
contribute 60% of the total malarial cases. 
With the resurgence of resistant strains of parasite and vectors malaria 
research has got a renewed interest. People are trying hard in malaria research 
with the orientation towards better understanding of Immunology, Biochemestry 
and biotogy of malaria pararite in order to develop effective coi^rol measure, 
fi"om, where the parasite can not evade. The worid health ergawrsatlon has also 
emphasised on research on chemotherapy of malaria including assesment and 
monitoring of drug sensitivity of malaria parasite. 
Researchers through out the worid have realized the impending danger 
posed by the tiny parasites. A ray of hope came to them when cytokines emerged 
at the arena of virology, later described for its role in immunomodulatory and 
Immunoregulatory activities. Interferon, again a cytokine, although was found as 
back as 1957 but was limited to viruses only. Later it was assessed against 
various other bacterial and protozoan infections. Different interferons have varied 
performance against these infectious agents. The interferons have been used with 
great succes as an adjuvent in the case of malaria as well as viruses, in AIDS 
virus yet another dimension of application of interferon has visualized. If 
administred in combination with AZT, it gives a profound effect and exponentiate 
(33) 
the effect of AZT the only seccessful AIDS drug. It thus, has the potential to 
reduce the dose of AZT which has got confined side effects. 
Interferons are reported to kill the malaria and other protozoan or bacterial 
parasites by inducing nitric oxide production, which, in turn kills the infectious 
agents. In malaria the interferons have little effect as blood schizontocial but does 
demonstrate a pronounced protective effect against tissue schizonts, probally 
through the killing of parasite via liver kuppfer celis. 
There is a range of compounds or agents that induce the various interferon, 
like dsRNA, poly IC:LC, NDV. statolong, cytokines, PHA, conA and 6-MFA, etc. 
poly IC:LC is lysine conjugated synthelic double stranded RNA. Statolon is a fungal 
product fi-om P. Stolonfferum. 6- MFA is another fungal agent that is mainly a/p 
interferon inducer. We produced it from the Aspergillus ochraceous culture. The 
fungal culture was performed under stationary flask culture in Shope memdia. 
After harvesting the micelial mat processing was done to yeild the final product, 
6-MFA. It was evaluated at 100 mg/kg body weight x 2 doses against Semliki 
Forest Virus in mice. There was 100% protection but no any prolonged immunity 
as the animals died on rechallenge with 10 LD50 virus ^^^^ ^^ ^^ y® ^^ protections. 
The 6-MFA batches produced by rotary flask culture method was not as effective 
as the stationary falsk culture mehtod, because, it protected only 40%, 50% and 
62.5% animals tested in various batches. 
Antimalarial profile of 6-MFA viras in similitude with other interferon or 
interferon inducers we found no protection against blood stage of multidrug 
resistant P. yoelii nigeriensis. But a significant increase in MST was, however 
recorded. In P. bergheivje had only 16.66 protection against blood schizonts but 
an elevation in MST was also noticed. Further analysis of the product is under 
investigation. 
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